![Yme Alkema](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Yme Alkema
Geen lopende functies
Loopbaan van Yme Alkema
Eerdere bekende functies van Yme Alkema
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Kiadis BV
![]() Kiadis BV Pharmaceuticals: MajorHealth Technology Kiadis BV is a drug discovery and development company with a focus on oncology and metabolic disorders. Kiadis has developed a proprietary technology platform, BioSelact technology that is used to perform drug discovery screening programs using natural extracts as well as synthetic mixtures and with the key advantage of direct identification and dereplication of the active compounds present in extracts or mixtures. The company is headquartered in Groningen, the Netherlands. | Corporate Officer/Principal | - | - |
BIOFRONTERA AG | Corporate Officer/Principal | - | - |
Atugen AG
![]() Atugen AG Pharmaceuticals: MajorHealth Technology Atugen AG is a biopharmaceutical company. It develops RNAi therapeutics which focus on vivo applications in oncology and liver diseases, exploiting its proprietary oligonucleotide delivery technologies and chemically stabilized siRNA structures. Founded in 1998, the company is headquartered in Berlin, Germany | Corporate Officer/Principal | 01-10-2005 | - |
Statistieken
Internationaal
Duitsland | 3 |
Nederland | 2 |
Operationeel
Corporate Officer/Principal | 3 |
Sectoraal
Health Technology | 4 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
BIOFRONTERA AG | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Kiadis BV
![]() Kiadis BV Pharmaceuticals: MajorHealth Technology Kiadis BV is a drug discovery and development company with a focus on oncology and metabolic disorders. Kiadis has developed a proprietary technology platform, BioSelact technology that is used to perform drug discovery screening programs using natural extracts as well as synthetic mixtures and with the key advantage of direct identification and dereplication of the active compounds present in extracts or mixtures. The company is headquartered in Groningen, the Netherlands. | Health Technology |
Atugen AG
![]() Atugen AG Pharmaceuticals: MajorHealth Technology Atugen AG is a biopharmaceutical company. It develops RNAi therapeutics which focus on vivo applications in oncology and liver diseases, exploiting its proprietary oligonucleotide delivery technologies and chemically stabilized siRNA structures. Founded in 1998, the company is headquartered in Berlin, Germany | Health Technology |
- Beurs
- Insiders
- Yme Alkema
- Ervaring